
Masimo Corporation MASI
$ 178.69
0.14%
Quarterly report 2025-Q3
added 11-04-2025
Country |
|
IPO year |
2007 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
53.3 M |
Market Cap[1] |
$ 9.52 B |
EBITDA (LTM) |
$ 293 M |
P/E (LTM) |
-45.87 |
P/S (LTM) |
6.52 |
EPS (LTM) |
-3.89 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
$ 70.49 | 0.36 % | $ 14 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.13 | -3.93 % | $ 228 M | Nasdaq Global Market | ||
|
Repro Med Systems
KRMD
|
$ 4.4 | -0.68 % | $ 203 M | Nasdaq Capital Market | ||
|
ICU Medical
ICUI
|
$ 129.4 | -0.41 % | $ 3.19 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 67.55 | -0.85 % | $ 4 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 26.03 | 0.81 % | $ 4.37 B | NYSE | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Pro-Dex
PDEX
|
$ 49.99 | 4.25 % | $ 164 M | Nasdaq Global Select Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 21.29 | 1.72 % | $ 1.43 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.5 | -0.94 % | $ 25.5 M | Nasdaq Capital Market | ||
|
Repligen Corporation
RGEN
|
$ 116.3 | -0.04 % | $ 6.48 M | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
STERIS plc
STE
|
$ 221.73 | 0.33 % | $ 21.9 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.8 | -1.91 % | $ 164 M | NYSE American | ||
|
Nephros
NEPH
|
$ 3.05 | -1.93 % | $ 31.7 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 56.66 | -3.08 % | $ 2.85 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 16.72 | 0.57 % | $ 8.58 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 106.56 | 0.67 % | $ 4.75 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.06 | -0.65 % | $ 225 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 10.63 | -0.75 % | $ 434 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 471.91 | -1.28 % | $ 168 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.61 | -0.57 % | $ 1.41 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.69 | 0.94 % | $ 200 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 63.8 | -2.04 % | $ 232 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 118.69 | 0.47 % | $ 3.8 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.7 | 2.76 % | $ 908 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 3.78 % | $ 23.1 M | NYSE American | ||
|
electroCore
ECOR
|
$ 6.17 | 0.65 % | $ 52.3 K | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 105.23 | -1.51 % | $ 5.1 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 245.27 | 1.6 % | $ 17.7 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 228.19 | 0.1 % | $ 33.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.5 | -0.79 % | $ 25.5 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.72 | -0.04 % | $ 21.6 M | NYSE American | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.47 | -0.65 % | $ 2.29 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 18.97 | 2.49 % | $ 940 M | Nasdaq Global Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.92 | -0.19 % | $ 44.9 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 109.99 | 1.97 % | $ 2.49 B | Nasdaq Global Market,SPB | ||
|
Alcon
ALC
|
$ 74.24 | 0.13 % | $ 40.4 B | NYSE |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.